No evidence of Singulair link to mood changes
This article was originally published in Scrip
Merck & Co's widely used asthma drug Singulair (montelukast) does not appear to be linked to mood changes, suicidality or suicide, American Lung Association researchers report in the Journal of Allergy and Clinical Immunology.
You may also be interested in...
Amgen's investigational bone loss treatment denosumab more than halves osteoporosis patients' risk of new vertebral fractures, new data from a pivotal Phase III trial show.
GlaxoSmithKlineand Xenoporthave submitted an NDA to the US FDAfor the once-daily restless legs syndrome drug Solzira (gabapentin enacarbil extended-release tablets), previously known as GSK1838262 by GSK and XP13512 by Xenoport.